Browse Pet Safety Reports
967,123 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 967,123 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 967,123 FDA veterinary adverse event reports for Dog.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Nov 6, 2025 | Dog | Terrier - Jack Russell | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Nov 6, 2025 | Dog | Cattle Dog - Australian (bl... | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Licking | Outcome Unknown |
| Nov 6, 2025 | Dog | Collie - Rough-haired | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Ehrlichia; Medication error NOS | Outcome Unknown |
| Nov 6, 2025 | Dog | Crossbred Canine/dog, Chihu... | Estriol | Dehydration; Fever; Decreased appetite | Ongoing |
| Nov 6, 2025 | Dog | Crossbred Canine/dog, Boxer... | Genta/Posacon/Mometa Eardrops | Lack of efficacy (bacteria) - NOS; Eardrum rupture | Ongoing |
| Nov 6, 2025 | Dog | Retriever - Labrador | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Vomiting | Recovered/Normal |
| Nov 6, 2025 | Dog | Shepherd Dog - Australian | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Nov 6, 2025 | Dog | Coonhound - Black and Tan, ... | Trilostane | Decreased appetite; Shaking; Dermatitis; Ulcerative dermatitis; Dermal nodule... | Outcome Unknown |
| Nov 6, 2025 | Dog | Terrier - Bull - American Pit | Pyrantel Pamoate;Sarolaner | Seizure NOS | Outcome Unknown |
| Nov 6, 2025 | Dog | Shepherd Dog - Belgian Mali... | Moxidectin | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Nov 6, 2025 | Dog | Shepherd (unspecified), Dog... | Bedinvetmab | Collapse NOS (see also Cardio-vascular and Neurological disorders); Lethargy ... | Ongoing |
| Nov 6, 2025 | Dog | Poodle - Miniature | Trilostane | Hyperphosphataemia; Hypercalcaemia; Weight loss; Inappropriate schedule of dr... | Outcome Unknown |
| Nov 6, 2025 | Dog | Bulldog - French | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Vomiting | Recovered/Normal |
| Nov 6, 2025 | Dog | Chihuahua | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Nov 6, 2025 | Dog | Mixed (Dog) | Afoxolaner | Scratching; Itchy skin; Licking; Chewing - pruritus (see also Oral cavity dis... | Outcome Unknown |
| Nov 6, 2025 | Dog | Terrier - Yorkshire | Lotilaner,Moxidectin,Praziquantel,Pyr... | Lethargy (see also Central nervous system depression in Neurological); Sleepi... | Recovered/Normal |
| Nov 6, 2025 | Dog | Chihuahua | Bedinvetmab | Increased skin sensitivity; Musculoskeletal disorder NOS; Local skin slough; ... | Recovered/Normal |
| Nov 6, 2025 | Dog | Retriever - Labrador | Afoxolaner | Lack of efficacy (endoparasite) - hookworm; Lack of efficacy (protozoa) - Coc... | Outcome Unknown |
| Nov 6, 2025 | Dog | Great Pyrenees | Melarsomine Dihydrochloride | Pain NOS; Diarrhoea; Injection site swelling; Injection site seroma; Injectio... | Ongoing |
| Nov 6, 2025 | Dog | Hound (unspecified) | Afoxolaner 150Mg / Moxidectin 720Mcg ... | Lack of efficacy (bacteria) - Anaplasma | Ongoing |
| Nov 6, 2025 | Dog | Retriever - Golden, Poodle ... | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm; Underdose; Medication error NOS | Ongoing |
| Nov 6, 2025 | Dog | Shepherd Dog - German | Bedinvetmab | Diarrhoea | Ongoing |
| Nov 6, 2025 | Dog | Spaniel - King Charles Cava... | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Nov 6, 2025 | Dog | Unknown | Florfenicol, Terbinafine, Mometasone ... | Head tremor; Lack of efficacy - NOS | Ongoing |
| Nov 6, 2025 | Dog | Shepherd Dog - German | Ilunocitinib | Purulent lesion(s); Abnormal cytology; Necrosis NOS; Cyanosis; Skin lesion NOS | Outcome Unknown |
| Nov 5, 2025 | Dog | Beagle | Bedinvetmab | Disorientation; Panting; Lethargy (see also Central nervous system depression... | Ongoing |
| Nov 5, 2025 | Dog | Retriever - Labrador, Dog (... | Lotilaner,Moxidectin,Praziquantel,Pyr... | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Nov 5, 2025 | Dog | Shepherd Dog - German, Dog ... | Maropitant Citrate | Emesis; Not eating; Lethargy (see also Central nervous system depression in N... | Ongoing |
| Nov 5, 2025 | Dog | Collie (unspecified) | Milbemycin Oxime | Vomiting; Emesis (multiple) | Outcome Unknown |
| Nov 5, 2025 | Dog | Crossbred Canine/dog, Chihu... | Fluralaner Powder For Inj Susp | Lethargy (see also Central nervous system depression in Neurological); Not ea... | Ongoing |
| Nov 5, 2025 | Dog | Spitz - German Pomeranian | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Lack of efficacy - NOS | Outcome Unknown |
| Nov 5, 2025 | Dog | Collie (unspecified), Dog (... | Meloxicam | Vomiting | Outcome Unknown |
| Nov 5, 2025 | Dog | Spaniel - King Charles Cava... | Lotilaner | Lack of efficacy - NOS; Other abnormal test result NOS; Cough | Outcome Unknown |
| Nov 5, 2025 | Dog | Shepherd Dog - German | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Nov 5, 2025 | Dog | Retriever - Golden | Fluralaner 13.64% 12-Week Chew | Emesis | Recovered/Normal |
| Nov 5, 2025 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Lethargy (see also Central nervous system depression in Neurological); Pantin... | Outcome Unknown |
| Nov 5, 2025 | Dog | Terrier - Yorkshire | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Nov 5, 2025 | Dog | Shepherd Dog - German | Oclacitinib Maleate | Lack of efficacy - NOS | Ongoing |
| Nov 5, 2025 | Dog | Hound (unspecified), Dog (u... | Melarsomine Dihydrochloride | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Nov 5, 2025 | Dog | Dog (unknown) | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Nov 5, 2025 | Dog | Bulldog - French | Chlorhexidine; Ophytrium | Excessive chewing, licking and/or grooming; Vocalisation; Facial swelling (se... | Ongoing |
| Nov 5, 2025 | Dog | Spaniel - Cocker American | Oclacitinib Maleate | Excessive chewing, licking and/or grooming; Pruritus; Lack of efficacy - NOS;... | Ongoing |
| Nov 5, 2025 | Dog | Coton de Tuléar | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Nov 5, 2025 | Dog | Pit Bull | Afoxolaner | Lack of efficacy (bacteria) - Ehrlichia | Outcome Unknown |
| Nov 5, 2025 | Dog | Shepherd (unspecified), Sib... | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Nov 5, 2025 | Dog | Terrier - Bull - American P... | Moxidectin | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Nov 5, 2025 | Dog | Akita | Carprofen | Lameness; Difficulty going up/down stairs; Collapse of leg | Ongoing |
| Nov 5, 2025 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
| Nov 5, 2025 | Dog | Bloodhound | Afoxolaner | Lack of efficacy (bacteria) - Ehrlichia; Lack of efficacy (ectoparasite) - ti... | Ongoing |
| Nov 5, 2025 | Dog | Shepherd Dog - Belgian Mali... | Estriol Tablets | Medication error NOS; Prescribing error; Lack of efficacy - NOS | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.